Posts

ARPA-H commits up to $125 million to on-demand personalized RNA medicines

on

The Francis Crick Institute and Medicines Discovery Catapult Open KQ Labs Applications, Accelerating the Next Wave of Data-Driven Health Innovation

on

Friday Five: Caris Life Sciences hits MCED market

on

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Use AI and Real‑World Data to Improve Clinical Trial Success

on

Zephyr AI Appoints Dr. Lisa Eli as Chief Scientific Officer

on

Aspen Neuroscience's Personalized Parkinson's Therapy Shows Early Promise with 12-Month Data

on

Spotlight On #ATTD2026: Digital Twins Edging Towards Routine Diabetes Care

on

PrecisionLife and Ovation Identify First Genetic Biomarkers to Predict GLP-1 Efficacy Response

on

Lilly Bests Novo Again, Rare Disease Week Goes Regulatory, More CDC Leadership Upheaval

on

Bayer and Vanderbilt University Medical Center Announce Five-Year Collaboration to Advance Cardiovascular and Kidney Disease Treatments

on

Accelerating Breast Cancer Treatment Planning with Agentic AI: Recent Advances and Implementations (2025)

on

Researchers Advance Toward Matching Patients with the Most Effective GLP-1 Drug for Personalized Obesity Treatment

on

Gate Bioscience Captures $65M Series B to Advance Molecular Gate Protein Degradation Platform

on

Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Highlighting Integration of Clinical Innovation, Multi-Omics, and AI for Solid Tumor Therapies

on

M42 and Oracle Join Forces to Advance Healthy Longevity and Disease Prevention

on

Companies Struggle to Accelerate Production of Bespoke mRNA Therapies

on

Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium

on

Recent Trends in Biomarker Testing for NSCLC: Maximizing Real-World Survival

on

Transforming Patient Data into Therapeutic Breakthroughs in 2025

on

Aerska Launches with $21M to Use Brain 'Shuttles' for RNAi Delivery in Neurological Diseases

on